Victory Capital Management Inc. Trims Stake in Astrana Health, Inc. (NASDAQ:ASTH)

Key Points

• Victory Capital Management Inc. has reduced its stake in Astrana Health, Inc. by 38.2%, selling 23,711 shares and holding 38,405 shares at a value of approximately $1.19 million.
• Astrana Health's stock price showed a significant decline, with a reported loss of $0.09 per share compared to analysts' expectations, despite a 53.4% year-over-year increase in revenue.
• Over half (52.77%) of Astrana Health's stock is held by hedge funds and institutional investors, reflecting a strong interest in the company from larger investment entities.

Victory Capital Management Inc. reduced its holdings in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 38.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 38,405 shares of the company's stock after selling 23,711 shares during the period. Victory Capital Management Inc. owned about 0.08% of Astrana Health worth $1,191,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. SteelPeak Wealth LLC grew its holdings in Astrana Health by 4.8% in the first quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company's stock valued at $17,619,000 after purchasing an additional 26,192 shares during the period. Linden Thomas Advisory Services LLC grew its holdings in Astrana Health by 11.9% in the first quarter. Linden Thomas Advisory Services LLC now owns 17,063 shares of the company's stock valued at $529,000 after purchasing an additional 1,816 shares during the period. Principal Financial Group Inc. grew its holdings in Astrana Health by 2.3% in the first quarter. Principal Financial Group Inc. now owns 221,896 shares of the company's stock valued at $6,881,000 after purchasing an additional 4,963 shares during the period. Illumine Investment Management LLC acquired a new stake in shares of Astrana Health in the first quarter worth approximately $566,000. Finally, City Center Advisors LLC acquired a new stake in shares of Astrana Health in the first quarter worth approximately $276,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Price Performance

Shares of NASDAQ:ASTH traded down $2.29 during trading on Friday, reaching $21.57. The stock had a trading volume of 638,034 shares, compared to its average volume of 301,057. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.70 and a current ratio of 1.70. The business has a fifty day moving average price of $24.60 and a 200-day moving average price of $29.58. The stock has a market cap of $1.21 billion, a PE ratio of 29.96, a PEG ratio of 0.79 and a beta of 0.85. Astrana Health, Inc. has a 1-year low of $21.43 and a 1-year high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The firm had revenue of $620.39 million during the quarter, compared to analyst estimates of $628.11 million. Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The business's revenue was up 53.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.31 earnings per share. On average, equities analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.